Evolving role of monoclonal antibodies in the treatment of chronic lymphocytic leukemia

Author： Kharfan-Dabaja Mohamed A Fahed Rabih Hussein Mohamad Santos Edgardo S

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.16, Iss.11, 2007-11, pp. : 1799-1815

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia

Current Cancer Drug Targets, Vol. 8, Iss. 2, 2008-03 ,pp. : 156-171

Bentham Science Publishers

Access to resources Recommend Favorite

New and Old Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 6, 2011-06 ,pp. : 508-518

Bentham Science Publishers

Access to resources Recommend Favorite

The role of high-dose corticosteroids in the treatment of chronic lymphocytic leukemia

By Smolej Lukáš

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 7, 2012-07 ,pp. : 1009-1017

Informa Healthcare

Access to resources Recommend Favorite

Bendamustine for treatment of chronic lymphocytic leukemia

By Chang Julie Elizabeth Kahl Brad Steven

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 10, 2012-07 ,pp. : 1495-1505

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibodies for the Treatment of Acute Myeloid Leukemia

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 5, 2006-10 ,pp. : 343-369

Bentham Science Publishers

Access to resources Recommend Favorite